-
1 . Academic Journal
A Phase I, Randomized, Multi‐Dose Study to Evaluate the Enteric Selectivity and Safety of JAK Inhibitor, Lorpucitinib, in Healthy Participants.
- 저자
- by Ma, Xuewen; Borzillo, Gary; Kothe, Martine J. Christine; Sanga, Madhu; Chu, Gerald, et al.
- 소스
- Clinical Pharmacology & Therapeutics; May2024, Vol. 115 Issue 5, p1075-1084, 10p